(2015) during an investigation on pulmonary hypertensive mice demonstrated that treatment with salidroside reduces RVH in treated mice and raises Caspase-3, BAX, A2aR and reduces BCL2 expression in PASMCs. The gene discussed is BAX; the disease is pulmonary hypertension.